Related Experiment Video
Updated: Jul 4, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Pediatric nonrhabdomyosarcoma soft tissue sarcomas
Sheri L Spunt1, Stephen X Skapek, Cheryl M Coffin
1Department of Oncology, St. Jude Children's Research Hospital, Department of Oncology, 332 N. Lauderdale Street, ALSAC-6032, Memphis, TN 38105-2794, USA. sheri.spunt@stjude.org
The Oncologist
|July 1, 2008
Summary
Nonrhabdomyosarcoma soft tissue sarcomas (NRSTSs) are rare childhood cancers. This review covers their epidemiology, pathogenesis, and treatment, highlighting differences from adult forms and risks for children.
Area of Science:
- Pediatric oncology
- Mesenchymal cell neoplasms
- Soft tissue sarcomas
Background:
- Nonrhabdomyosarcoma soft tissue sarcomas (NRSTSs) represent approximately 4% of pediatric malignancies.
- The rarity of individual histologic subtypes hinders comprehensive study of their biology, natural history, and optimal management.
- Existing data from adult soft tissue sarcomas offer limited applicability due to distinct subtype distributions and differing behaviors in children.
Purpose of the Study:
- To consolidate current knowledge on childhood NRSTSs.
- To provide an overview of epidemiology, pathogenesis, and clinical approaches.
- To inform diagnosis and treatment strategies for these rare pediatric tumors.
Main Methods:
- Literature review and synthesis of existing data on childhood NRSTSs.
- Analysis of epidemiological trends and pathogenetic mechanisms.
- Evaluation of diagnostic and therapeutic strategies, considering pediatric-specific factors.
Main Results:
- Childhood NRSTSs exhibit unique histologic subtype distributions compared to adult populations.
- Certain NRSTS entities demonstrate distinct clinical behaviors in pediatric patients.
- Treatment planning must account for heightened risks associated with therapies like radiotherapy in children.
Conclusions:
- A comprehensive understanding of childhood NRSTSs is crucial due to their rarity and distinct characteristics.
- Tailored treatment approaches are necessary, considering age-specific tumor behavior and treatment toxicities.
- Further research is warranted to elucidate the biology and optimize outcomes for pediatric NRSTS.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...